Rallybio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rallybio and other ETFs, options, and stocks.About RLYB
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease.
CEOStephen Uden
CEOStephen Uden
Employees25
Employees25
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2018
Founded2018
Employees25
Employees25
RLYB Key Statistics
Market cap33.16M
Market cap33.16M
Price-Earnings ratio-2.46
Price-Earnings ratio-2.46
Dividend yield—
Dividend yield—
Average volume238.93K
Average volume238.93K
High today$0.79
High today$0.79
Low today$0.7549
Low today$0.7549
Open price$0.7766
Open price$0.7766
Volume170.83K
Volume170.83K
52 Week high$1.08
52 Week high$1.08
52 Week low$0.2201
52 Week low$0.2201
Stock Snapshot
The current Rallybio(RLYB) stock price is $0.75, with a market capitalization of 33.16M. The stock trades at a price-to-earnings (P/E) ratio of -2.46.
On 2025-12-20, Rallybio(RLYB) stock traded between a low of $0.75 and a high of $0.79. Shares are currently priced at $0.75, which is 0.0% above the low and -4.4% below the high.
The Rallybio(RLYB)'s current trading volume is 170.83K, compared to an average daily volume of 238.93K.
In the last year, Rallybio(RLYB) shares hit a 52-week high of $1.08 and a 52-week low of $0.22.
In the last year, Rallybio(RLYB) shares hit a 52-week high of $1.08 and a 52-week low of $0.22.
People also own
Based on the portfolios of people who own RLYB. This list is generated using Robinhood data, and it’s not a recommendation.